Cover Image

Evaluation of pregnancy outcomes using medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist in ovarian stimulation: A retrospective cohort study

Abstract Background: Limited studies have compared pregnancy outcomes with medroxyprogesterone acetate (MPA) vs. gonadotropin-releasing hormone antagonist (GnRH antagonist) in ovarian stimulation protocols. The results show heterogeneity. Objective: This study aims to assess pregnancy outcomes with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ekika Singh (Author), Christophe Blockeel (Author), Madhulika Singh (Author), Rishi Gupta (Author), Sandesh Kamdi (Author)
Format:	Book
Published:	Shahid Sadoughi University of Medical Sciences, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
by: Shikha Jain, et al.
Published: (2016)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
by: Richard Fleming, Ph.D
Published: (2023)

Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome
by: Runa Ozelci, et al.
Published: (2019)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
by: Batool Hossein Rashidi, et al.
Published: (2015)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D
Published: (2023)

Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
by: Puneet Kaur Kochhar, et al.
Published: (2020)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021)

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
by: Emons Günter, et al.
Published: (2003)

Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study
by: Huang J, et al.
Published: (2020)

Type and dose of gonadotropins in poor ovarian responders: does it matter?
by: Liese Boudry, et al.
Published: (2021)

Progress in Clinical Research on Gonadotropin-Releasing Hormone Receptor Antagonists for the Treatment of Prostate Cancer
by: Liu YF, et al.
Published: (2021)

Relationship of gonadotropin hormone levels with testicular dysfunction in patients suffered from varicocele before and after stimulation by gonadotropin releasing hormone
by: Majid Shirani, et al.
Published: (2017)

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women
by: Yung-Ling Chang, et al.
Published: (2006)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
by: Chen Q, et al.
Published: (2019)

Minimal Stimulation Using Gonadotropin-Releasing Hormone Antagonist is Associated with Higher Live Birth Rates: A National Study of 13,050 Cycles
by: Emily G. Hurley, et al.
Published: (2022)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
by: Cornelis B. Lambalk, M.D., Ph.D
Published: (2023)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial
by: Jared C. Robins, M.D, et al.
Published: (2020)

Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
by: Wignall Jacqui, et al.
Published: (2010)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
by: Neena Malhotra, et al.
Published: (2013)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014)

Effect of body mass index on progesterone level on trigger day in gonadotropin-releasing hormone antagonist cycles
by: Yating Sun, et al.
Published: (2024)

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women
by: Yi Xu, et al.
Published: (2022)

Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study
by: Abbas Aflatoonian, et al.
Published: (2018)

Comparison of two regimens of gonadotropin-releasing hormone antagonists in clomiphene-gonadotropin induced controlled ovulation and intrauterine insemination cycles: Randomized controlled study
by: Sajja Devendra Siva Karthik, et al.
Published: (2018)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022)

Medroxyprogesterone Acetate Plus Metformin to Prevent Persistent Endometrial Hyperplasia
by: Vakkas Korkmaz, et al.
Published: (2016)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS Maryam
by: Maryam Eftekhar, et al.
Published: (2016)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
by: Rohit Gutgutia, et al.
Published: (2014)

Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
by: Siti Nadirah Ab Rahim, et al.
Published: (2020)

Gonadotropin-Releasing Hormone Receptor Signaling and Functions
by: Stanko S. Stojilkovic
Published: (2018)

Gonadotropin-releasing hormone: incredible 50 years
by: Richard J. Paulson, M.D., M.S, et al.
Published: (2023)

Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer
by: Xiaoyan Ding, et al.
Published: (2021)

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
by: Lam C, et al.
Published: (2016)

Effect of depot-medroxyprogesterone acetate injections on serum immunoglobulins and complements level
by: Wahda B. Al-Youzbaki
Published: (2008)

Effectiveness of the triptorelin stimulation test compared with the classic gonadotropin-releasing hormone stimulation test in diagnosing central precocious puberty in girls
by: Yu Jin Kim, et al.
Published: (2024)

Effects of human growth hormone on gonadotropin-releasing hormone neurons in mice
by: Janardhan P. Bhattarai, et al.
Published: (2010)

The potential regulatory mechanisms of the gonadotropin-releasing hormone in gonadotropin transcriptions identified with bioinformatics analyses
by: Wei Xiang, et al.
Published: (2017)

Early preclinical work with gonadotropin-releasing hormone analogues
by: Keith Gordon, Ph.D
Published: (2023)